PURPOSE: Many prostate cancer survivors experience compromised health-related quality of life (HRQOL) as a result of prostate cancer. We examined relationships between types and intensities of activity and sedentary behavior and prostate cancer-related HRQOL, overall, and by demographic, disease, and treatment characteristics. METHODS: Associations between post-diagnosis activity and sedentary behavior and HRQOL domains (urinary incontinence, urinary irritation/obstruction, bowel, sexual, and vitality/hormonal) were prospectively examined in men diagnosed with non-metastatic prostate cancer in the Health Professionals Follow-up Study (n = 1917) using generalized linear models. RESULTS: After adjusting for potential confounders, higher duration of total, non-vigorous, and walking activity was associated with higher vitality/hormonal functioning scores (p-trends, <0.0001). Effects were small (d = 0.16-0.20) but approached clinical significance for men in the highest vs. lowest activity categories. Survivors who walked ≥ 90 min/week at a normal pace, or faster, reported higher hormone/vitality scores (p = 0.001) than men walking <90 min at an easy pace. Weightlifting was associated with increased urinary incontinence (p-trend, 0.02). Total activity was associated with higher hormone/vitality functioning in men who were ≥ 5 years post-treatment, had more advanced disease (Gleason score ≥ 7), and had ≥ 1 comorbid condition. No relationships were observed between vigorous activity or sedentary behavior and HRQOL. CONCLUSIONS: Increased duration of non-vigorous activity and walking post-diagnosis was positively associated with better hormone/vitality functioning. Specifically, engaging in ≥ 5 h of non-vigorous activity or ≥ 3 h of walking per week may be beneficial. IMPLICATIONS FOR CANCER SURVIVORS: Encouraging men to engage in non-vigorous activity and walking may be helpful for managing prostate cancer-related HRQOL.
PURPOSE: Many prostate cancer survivors experience compromised health-related quality of life (HRQOL) as a result of prostate cancer. We examined relationships between types and intensities of activity and sedentary behavior and prostate cancer-related HRQOL, overall, and by demographic, disease, and treatment characteristics. METHODS: Associations between post-diagnosis activity and sedentary behavior and HRQOL domains (urinary incontinence, urinary irritation/obstruction, bowel, sexual, and vitality/hormonal) were prospectively examined in men diagnosed with non-metastatic prostate cancer in the Health Professionals Follow-up Study (n = 1917) using generalized linear models. RESULTS: After adjusting for potential confounders, higher duration of total, non-vigorous, and walking activity was associated with higher vitality/hormonal functioning scores (p-trends, <0.0001). Effects were small (d = 0.16-0.20) but approached clinical significance for men in the highest vs. lowest activity categories. Survivors who walked ≥ 90 min/week at a normal pace, or faster, reported higher hormone/vitality scores (p = 0.001) than men walking <90 min at an easy pace. Weightlifting was associated with increased urinary incontinence (p-trend, 0.02). Total activity was associated with higher hormone/vitality functioning in men who were ≥ 5 years post-treatment, had more advanced disease (Gleason score ≥ 7), and had ≥ 1 comorbid condition. No relationships were observed between vigorous activity or sedentary behavior and HRQOL. CONCLUSIONS: Increased duration of non-vigorous activity and walking post-diagnosis was positively associated with better hormone/vitality functioning. Specifically, engaging in ≥ 5 h of non-vigorous activity or ≥ 3 h of walking per week may be beneficial. IMPLICATIONS FOR CANCER SURVIVORS: Encouraging men to engage in non-vigorous activity and walking may be helpful for managing prostate cancer-related HRQOL.
Authors: Brigid M Lynch; Ester Cerin; Neville Owen; Anna L Hawkes; Joanne F Aitken Journal: Cancer Causes Control Date: 2011-06-09 Impact factor: 2.506
Authors: Eva Johansson; Gunnar Steineck; Lars Holmberg; Jan-Erik Johansson; Tommy Nyberg; Mirja Ruutu; Anna Bill-Axelson Journal: Lancet Oncol Date: 2011-08-05 Impact factor: 41.316
Authors: Brigid M Lynch; David W Dunstan; Genevieve N Healy; Elisabeth Winkler; Elizabeth Eakin; Neville Owen Journal: Cancer Causes Control Date: 2009-11-01 Impact factor: 2.506
Authors: Stephanie M George; Catherine M Alfano; Jay Groves; Zafer Karabulut; Kirsten L Haman; Barbara A Murphy; Charles E Matthews Journal: PLoS One Date: 2014-02-05 Impact factor: 3.240
Authors: Joshua Petimar; Stephanie A Smith-Warner; Bernard Rosner; Andrew T Chan; Edward L Giovannucci; Fred K Tabung Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-06-24 Impact factor: 4.254
Authors: Erika Rees-Punia; Alpa V Patel; Joseph R Nocera; Sicha Chantaprasopsuk; Wendy Demark-Wahnefried; Corinne R Leach; Tenbroeck G Smith; David Cella; Susan M Gapstur Journal: Cancer Date: 2020-10-20 Impact factor: 6.921
Authors: Linda Trinh; Shabbir M H Alibhai; Nicole Culos-Reed; Catherine M Sabiston; Jennifer M Jones; Dori E Rosenberg; Alexis Whitehorn; Denise Bastas; Guy E Faulkner Journal: J Behav Med Date: 2022-01-21
Authors: Anthony Barnett; Ester Cerin; Casper J P Zhang; Cindy H P Sit; Janice M Johnston; Martin M C Cheung; Ruby S Y Lee Journal: Int J Behav Nutr Phys Act Date: 2016-04-21 Impact factor: 6.457
Authors: Linda Trinh; Kelly P Arbour-Nicitopoulos; Catherine M Sabiston; Scott R Berry; Andrew Loblaw; Shabbir M H Alibhai; Jennifer M Jones; Guy E Faulkner Journal: Int J Behav Nutr Phys Act Date: 2018-06-07 Impact factor: 6.457
Authors: Agnieszka Lemanska; Karen Poole; Jonathan J Aning; Bruce A Griffin; Ralph Manders; John M Saxton; Joe Wainwright; Sara Faithfull Journal: Eur Rev Aging Phys Act Date: 2019-01-10 Impact factor: 3.878
Authors: Teresa Lam; Birinder Cheema; Amy Hayden; Stephen R Lord; Howard Gurney; Shivanjini Gounden; Navneeta Reddy; Haleh Shahidipour; Scott Read; Glenn Stone; Mark McLean; Vita Birzniece Journal: Sports Med Open Date: 2020-12-14